Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70366 |
IRBESARTAN | 150MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70369 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-03 | 2019-01-16 | 71060 |
MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-01-16 | 2019-03-05 | 72434 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2019-01-21 | 2020-07-20 | 73141 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
VAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58386 |
VAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58389 |